+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Solid Organ Transplantation Rejection Market by Rejection Type, Offering, Type Of Organ Transplant, End User - Global Forecast to 2030- Product Image
Solid Organ Transplantation Rejection Market by Rejection Type, Offering, Type Of Organ Transplant, End User - Global Forecast to 2030- Product Image
Sale

Solid Organ Transplantation Rejection Market by Rejection Type, Offering, Type Of Organ Transplant, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977994
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking actionable insight into the Solid Organ Transplantation Rejection Market will find this report essential for navigating shifting dynamics, regulatory complexities, and rising clinical demands. As healthcare delivery models evolve and transformative therapies reshape patient care, leaders face new challenges and opportunities in optimizing outcomes, cost structures, and competitive positioning.

Market Snapshot: Solid Organ Transplantation Rejection Market

The global Solid Organ Transplantation Rejection Market grew from USD 8.74 billion in 2024 to USD 9.19 billion in 2025, driven by increasing transplant volumes and rapid advancements in immunosuppression and diagnostics. The market is projected to post a healthy CAGR of 5.36% to reach USD 11.95 billion by 2030. Demand for personalized therapies, robust diagnostics, and operational efficiency is escalating among hospitals and healthcare systems worldwide. Segment-specific innovation and adaptive regulatory environments further accelerate market developments, prompting both established firms and emerging players to enhance their offerings and strategic footprint.

Scope & Segmentation

  • Rejection Types: Acute, Chronic, Hyperacute—each requiring differentiated diagnostic and therapeutic approaches.
  • Offerings:
    • Diagnosis & Testing Solutions: Blood Tests, Imaging Tests, Tissue Biopsy.
    • Medications: Antibodies, Antimetabolites, Calcineurin Inhibitors, Steroids.
  • Organ Transplants: Heart, Kidney, Liver, Lung, Pancreas—each presenting varying supply constraints and risk profiles.
  • End Users: Hospitals & Transplant Centers, Research Institutes, Specialty Clinics, with unique needs for procurement and monitoring.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, South Africa, among others); Asia-Pacific (including China, India, Japan, Australia, South Korea, and others).
  • Leading Companies: Abbott Laboratories, Accord Healthcare, Asahi Kasei, Astellas Pharma, Biocon, Cipla, Eurofins Transplant Diagnostics, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi, Thermo Fisher, Zydus Lifesciences, among others.

Key Takeaways

  • Advancements in cell-based therapies and gene editing are modernizing rejection prevention, supplementing conventional immunosuppression regimens for improved clinical outcomes.
  • Precision medicine and digital health platforms enable risk stratification, predictive analytics, and remote patient monitoring, streamlining care while lowering adverse event rates.
  • Regional growth patterns reveal that Asia-Pacific is outpacing other geographies due to localized manufacturing, streamlined regulations, and scalable digital solutions.
  • Procurement strategies are shifting as organizations adapt to new supply chain risks, focusing on domestic manufacturing and resilient sourcing.
  • Collaborative partnerships among pharmaceutical, biotech, and technology firms are intensifying, driving the co-development of innovative diagnostics and therapies.
  • Diversification of reimbursement models and data-driven clinical evidence is increasingly central to achieving market access and payer alignment.

Tariff Impact

Recent United States tariffs on imported reagents, diagnostics equipment, and key specialty pharmaceuticals have introduced substantial cost pressures. Transplant centers and labs face higher procurement costs, often prompting a move toward domestically manufactured alternatives and updated supplier contracts. Increased tariffs have also pushed up reimbursement rates, impacting payer budgets and influencing patient access to advanced testing methodologies. Pharmaceuticals, such as monoclonal antibodies, have been affected, with manufacturers balancing cost absorption and downstream price adjustments. Organizations are prioritizing supply chain diversification by establishing buffer inventories and alternative sourcing, supporting greater resilience in the face of regulatory and trade uncertainties.

Methodology & Data Sources

This report uses a multi-tiered research approach, combining input from transplant clinicians, immunology experts, and laboratory directors with in-depth secondary analysis of journals, regulatory filings, and proprietary databases. Extensive secondary data verification ensures findings are robust, consistent, and reflective of current industry realities.

Why This Report Matters

  • Offers comprehensive market intelligence for guiding investment decisions and strategic planning in a rapidly changing transplant landscape.
  • Equips stakeholders with actionable insights on regulation, technology adoption, risk mitigation, and competitive positioning across major regions and end-user categories.

Conclusion

In summary, the Solid Organ Transplantation Rejection Market is undergoing rapid transformation driven by innovation, new regulatory approaches, and changing supply chain dynamics. Leaders who engage with integrated diagnostics, resilient sourcing, and collaborative partnerships will be best positioned to deliver improved patient outcomes and sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Solid Organ Transplantation Rejection Market, by Rejection Type
8.1. Introduction
8.2. Acute Rejection
8.3. Chronic Rejection
8.4. Hyperacute Rejection
9. Solid Organ Transplantation Rejection Market, by Offering
9.1. Introduction
9.2. Diagnosis & Testing Solutions
9.2.1. Blood Tests
9.2.2. Imaging Tests
9.2.3. Tissue Biopsy
9.3. Medications
9.3.1. Antibodies
9.3.2. Antimetabolites
9.3.3. Calcineurin Inhibitors
9.3.4. Steroids
10. Solid Organ Transplantation Rejection Market, by Type Of Organ Transplant
10.1. Introduction
10.2. Heart
10.3. Kidney
10.4. Liver
10.5. Lung
10.6. Pancreas
11. Solid Organ Transplantation Rejection Market, by End User
11.1. Introduction
11.2. Hospitals & Transplant Centers
11.3. Research Institutes
11.4. Specialty Clinics
12. Americas Solid Organ Transplantation Rejection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Solid Organ Transplantation Rejection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Solid Organ Transplantation Rejection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Accord Healthcare Limited
15.3.3. Asahi Kasei Corporation
15.3.4. Astellas Pharma Inc.
15.3.5. Biocon
15.3.6. Cipla Ltd.
15.3.7. Dr. Reddy’s Laboratories Ltd.
15.3.8. Eurofins Transplant Diagnostics
15.3.9. F. Hoffmann-La Roche Ltd.
15.3.10. GlaxoSmithKline PLC
15.3.11. Globela Pharma
15.3.12. Lupin Limited
15.3.13. Manus Aktteva Biopharma LLP
15.3.14. Natco Pharma Ltd.
15.3.15. Novartis AG
15.3.16. Panacea Biotec Pharma Ltd.
15.3.17. Pfizer Inc.
15.3.18. Plexision
15.3.19. Sanofi S.A.
15.3.20. Strides Pharma Global Pte Ltd.
15.3.21. Thermo Fisher Scientific Inc.
15.3.22. Veloxis Pharmaceuticals A/S
15.3.23. Zydus Lifesciences Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET MULTI-CURRENCY
FIGURE 2. SOLID ORGAN TRANSPLANTATION REJECTION MARKET MULTI-LANGUAGE
FIGURE 3. SOLID ORGAN TRANSPLANTATION REJECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 48. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 49. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 50. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 51. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 84. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 85. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 86. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 87. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 88. GERMANY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 91. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 92. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 103. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 104. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 105. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 106. ITALY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 108. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 109. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 110. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 112. SPAIN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 133. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 135. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 144. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 145. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 146. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 148. QATAR SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 151. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 152. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 153. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 154. FINLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 169. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 170. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 171. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 172. EGYPT SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 175. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 176. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 177. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 187. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 188. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 189. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 190. NORWAY SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 192. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 193. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 194. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 195. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 196. POLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 211. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 212. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 213. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 214. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 215. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 218. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 219. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 220. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 221. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 224. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 225. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 226. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 227. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 248. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 250. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 251. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY TYPE OF ORGAN TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2024
TABLE 283. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Solid Organ Transplantation Rejection market report include:
  • Abbott Laboratories
  • Accord Healthcare Limited
  • Asahi Kasei Corporation
  • Astellas Pharma Inc.
  • Biocon
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eurofins Transplant Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Globela Pharma
  • Lupin Limited
  • Manus Aktteva Biopharma LLP
  • Natco Pharma Ltd.
  • Novartis AG
  • Panacea Biotec Pharma Ltd.
  • Pfizer Inc.
  • Plexision
  • Sanofi S.A.
  • Strides Pharma Global Pte Ltd.
  • Thermo Fisher Scientific Inc.
  • Veloxis Pharmaceuticals A/S
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.95 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035 - Product Image

Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035

  • Report
  • 140 Pages
  • Global
From
Tissue And Organ Transplantation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Tissue And Organ Transplantation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Transplantation Market by Product, Application, End User, and Region 2025-2033 - Product Image

Transplantation Market by Product, Application, End User, and Region 2025-2033

  • Report
  • 123 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report - Product Image

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.